We are excited to announce that our CEO, Dr. David Liang, has been appointed as an Editor for the esteemed Computational and Structural Biotechnology Journal. This leading journal focuses on computational methods, structural biology, and biotechnology—critical fields driving transformative advances in science and technology. The rapid evolution of these areas is exemplified by the 2024 Nobel Prize in Chemistry, awarded to David Baker for his groundbreaking work in computational protein design, and to Demis Hassabis and John Jumper for their pioneering contributions to protein structure prediction.
Dr. Liang’s appointment reflects his ongoing commitment to advancing scientific knowledge and promoting collaboration between academia and industry. In this new role, he will contribute to the journal’s mission of sharing innovative discoveries and advancing cutting-edge breakthroughs in biotechnology.
Dr. Liang expressed his deep gratitude to the scientific community for their continued support and looks forward to working together to push the boundaries of protein science.
SHARE
